• Privacy policy
  • T&C’s
  • About Us
    • FAQ
  • Contact us
  • Guest Content
  • TLE
  • News
  • Politics
  • Opinion
    • Elevenses
  • Business
  • Food
  • Travel
  • Property
  • JOBS
  • All
    • All Entertainment
    • Film
    • Sport
    • Tech/Auto
    • Lifestyle
    • Lottery Results
      • Lotto
      • Set For Life
      • Thunderball
      • EuroMillions
No Result
View All Result
The London Economic
SUPPORT THE LONDON ECONOMIC
NEWSLETTER
The London Economic
No Result
View All Result
Home Business and Economics Business

‘Reprehensible choice:’ Tobacco firm Philip Morris’s controversial bid for asthma firm goes to auction

“We are also deeply troubled that this company could further profit from the disease their products have caused by now selling therapies to the same people who were sickened by smoking PMI cigarettes," said the American Lung Association.

Joe Mellor by Joe Mellor
2021-08-09 11:48
in Business
FacebookTwitterLinkedinEmailWhatsapp

Tobacco maker Philip Morris and US private equity company Carlyle are primed for a £1 billion battle to take over inhaler-maker Vectura.

The Takeover Panel, which regulates acquisitions of listed companies in the UK, said that Vectura would go to auction following back-and-forth bids from the two businesses.

The companies will now have a week, starting on Tuesday, to place their bids.

The takeover process for Vectura, which makes asthma medicine, started in May when Carlyle approached the FTSE 250-listed firm with a £958 million bid.

The bid immediately gained the backing of Vectura’s board, which said that the price would give cash to shareholders today for advances the company would have made in the future.

But last month, Vectura’s directors switched their allegiance to Philip Morris, which muscled into Carlyle’s bid with an offer of its own.

That the maker of Marlboro cigarettes wanted to buy an asthma company raised eyebrows from doctors and politicians.

“Reprehensible choice”

A shared statement American Lung Association president Harold Wimmer and American Thoracic Society president Lynn Schnapp called the move a “reprehensible choice” by Philip Morris.

“The announcement that Philip Morris International (PMI) wants to acquire an inhaled medicine company is the latest reprehensible choice from a company that has profited from addicting users to its deadly products.

RelatedPosts

Shops could be forced to accept cash in future

Liverpool to introduce tourist tax from June

Labour’s bid to build 1.5 million new homes gets underway

Deliveroo drivers protest over ‘soul-destroying’ working conditions outside AGM

“We are deeply concerned that PMI will use the inhalation services technologies developed by Vectura to make their tobacco products more addictive.

“We are also deeply troubled that this company could further profit from the disease their products have caused by now selling therapies to the same people who were sickened by smoking PMI cigarettes.”

They called on the UK Government to stop the sale, adding their voices to similar demands from the Labour Party.

For Philip Morris the acquisition represents a way to move beyond nicotine. Non-tobacco products are making up an increasingly large part of the business’s portfolio.

So when Carlyle returned with a new bid for Vectura last week, which was backed by Vectura’s board, Philip Morris was quick to up its own offer over the weekend.

The latest bids forced the Takeover Panel’s hand, and it stepped in on Monday to announce an auction process.

Related: Council to ban smoking outdoors and some people really aren’t happy about it

Subscribe to our Newsletter

View our  Privacy Policy and Terms & Conditions

About Us

TheLondonEconomic.com – Open, accessible and accountable news, sport, culture and lifestyle.

Read more

SUPPORT

We do not charge or put articles behind a paywall. If you can, please show your appreciation for our free content by donating whatever you think is fair to help keep TLE growing and support real, independent, investigative journalism.

DONATE & SUPPORT

Contact

Editorial enquiries, please contact: [email protected]

Commercial enquiries, please contact: [email protected]

Address

The London Economic Newspaper Limited t/a TLE
Company number 09221879
International House,
24 Holborn Viaduct,
London EC1A 2BN,
United Kingdom

© The London Economic Newspaper Limited t/a TLE thelondoneconomic.com - All Rights Reserved. Privacy

No Result
View All Result
  • Home
  • News
  • Politics
  • Lottery Results
    • Lotto
    • Set For Life
    • Thunderball
    • EuroMillions
  • Business
  • Sport
  • Entertainment
  • Lifestyle
  • Food
  • Travel
  • JOBS
  • More…
    • Elevenses
    • Opinion
    • Property
    • Tech & Auto
  • About Us
    • Privacy policy
  • Contact us

© The London Economic Newspaper Limited t/a TLE thelondoneconomic.com - All Rights Reserved. Privacy

← Watch: Dave Grohl trolls Westboro Baptist Church in the best way possible ← Climate emergency: ‘Code red for humanity’ as Thunberg urges world to ‘be brave’
No Result
View All Result
  • Home
  • News
  • Politics
  • Lottery Results
    • Lotto
    • Set For Life
    • Thunderball
    • EuroMillions
  • Business
  • Sport
  • Entertainment
  • Lifestyle
  • Food
  • Travel
  • JOBS
  • More…
    • Elevenses
    • Opinion
    • Property
    • Tech & Auto
  • About Us
    • Privacy policy
  • Contact us

© The London Economic Newspaper Limited t/a TLE thelondoneconomic.com - All Rights Reserved. Privacy

-->